Published in J Exp Med on September 01, 1978
Monoclonal antibody against an Ir gene product? J Exp Med (1980) 3.88
Functional analysis of T cells expressing Ia antigens. I. Demonstration of helper T-cell heterogeneity. J Exp Med (1979) 1.53
Differential endocytosis of T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate. Proc Natl Acad Sci U S A (1982) 1.14
Monoclonal antibodies that recognize the product controlled by a gene in the I-J subregion of the mouse H-2 complex. J Exp Med (1981) 1.13
I-N: a newly described H-2 I subregion between K and I-A. J Exp Med (1980) 0.98
Generation of primary cytotoxic lymphocytes against non-major histocompatibility complex antigens by anti-Ia serum plus complement-treated lymphocytes. J Exp Med (1980) 0.94
Murine T cell Ia antigens: specificity Iat.46 maps in I-J to I-E chromosomal segment of H-2 complex. Proc Natl Acad Sci U S A (1980) 0.79
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
Histocompatibility-linked immune response genes. Science (1972) 16.79
Cell interactions between histoincompatible T and B lymphocytes. VII. Cooperative responses between lymphocytes are controlled by genes in the I region of the H-2 complex. J Exp Med (1975) 7.64
A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes. J Exp Med (1976) 6.11
A mouse B-cell alloantigen determined by gene(s) linked to the major histocompatibility complex. J Exp Med (1973) 5.55
The role of macrophages in the generation of T-helper cells. II. The genetic control of the macrophage-T-cell interaction for helper cell induction with soluble antigens. J Exp Med (1975) 5.48
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
New lymphocyte antigen system (Lna) controlled by the Ir region of the mouse H-2 complex. Proc Natl Acad Sci U S A (1973) 4.45
Genetic control of the immune response. Mapping of the Ir-1 locus. J Exp Med (1972) 3.96
Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56
Serological identification of an Ir-region product. Science (1973) 3.32
Activation of T and B lymphocytes in vitro. III. Presence of Ia determinants on allogeneic effect factor. J Exp Med (1974) 3.29
Separation of suppressor and killer T cells by surgace phenotype. Nature (1976) 3.03
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12
Expression of individual Ia specificities on T and B cells. I. Studies with mitogen-induced blast cells. J Exp Med (1976) 2.08
Serologic evidence for antigens controlled by the Ir region in mice. J Exp Med (1973) 1.94
Serological and functional evidence for further subdivision of the I regions of the H-2 gene complex. Cold Spring Harb Symp Quant Biol (1977) 1.91
Graft-versus-host reactions across different regions of the H-2 complex of the mouse. J Exp Med (1973) 1.87
Tissue distribution of I region-associated antigens in the mouse. J Immunol (1974) 1.76
Ia alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter. J Immunol (1975) 1.65
Tla types of H-2 congenic and recombinant mice. Transplantation (1974) 1.62
Graft versus host reaction in strains of mice identical for H-2K and H-2D antigens. Nat New Biol (1973) 1.61
Effects of anti-Ia sera on mitogenic responses. III. Mapping the genes controlling the expression of Ia determinants on concanavalin A-reactive cells to the I-J subregion of the H-2 gene complex. J Exp Med (1976) 1.60
Fc-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes. J Exp Med (1975) 1.32
The presence of I-region-associated antigens on B cells in molecules distinct from immunoglobulin and H-2K and H-2D. Proc Natl Acad Sci U S A (1974) 1.31
Ficoll flotation for the separation of blood leukocyte types. Blood (1968) 1.27
Partial characterisation of Ia antigens on murine thymocytes. Nature (1975) 1.18
The role of gene products of the I-J subregion in mixed lymphocyte reactions. J Exp Med (1977) 1.12
Cellular responses to murine alloantigens of the major histocompatibility complex: the role of cell subpopulations that express different quantities of H-2 associated antigenic markers. Eur J Immunol (1976) 0.98
Immunochemical evidence for three Ia loci in the I-region of the H-2 complex. J Exp Med (1977) 0.96
Direct visualization of T lymphocytes bearing Ia antigens controlled by the I-J subregion. J Exp Med (1977) 0.85
The Tla locus: a new allele and antigenic specificity. J Immunol (1977) 0.82
The NMR phased array. Magn Reson Med (1990) 11.94
The lectins: carbohydrate-binding proteins of plants and animals. Adv Carbohydr Chem Biochem (1978) 6.92
One-way stimulation in mixed leukocyte cultures. Science (1966) 6.62
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med (2000) 6.32
Histocompatibility matching. VI. Miniaturization of the mixed leukocyte culture test: a preliminary report. Transplantation (1971) 5.43
Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med (1972) 4.59
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc Natl Acad Sci U S A (1980) 4.35
Differential function of major histocompatibility complex antigens in T-lymphocyte activation. Nature (1976) 3.87
Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med (2000) 3.41
The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment. Transplant Proc (1973) 3.35
Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor. Cell Immunol (1972) 3.35
Cell-mediated lympholysis. Importance of serologically defined H-2 regions. J Exp Med (1973) 3.34
Hu-1: Major histocompatibility locus in man. Science (1967) 3.13
Cell mediated immunity: separation of cells involved in recognitive and destructive phases. Science (1973) 3.04
Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med (1968) 3.00
1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A (1996) 2.95
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem (1996) 2.79
Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J (1993) 2.75
Detection of a novel human class II HLA antigen. Nature (1983) 2.61
Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med (1998) 2.40
Genetic and immunological complexity of major histocompatibility regions. Science (1972) 2.40
Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet (1968) 2.29
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J Biol Chem (1996) 2.26
DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J Exp Med (1991) 2.14
A sensitive fluorescent method for the detection of glycoproteins in polyacrylamide gels. Anal Biochem (1976) 2.13
1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr (1998) 2.06
Role of H-2 lymphocyte-defined and serologically-defined components in the generation of cytotoxic lymphocytes. J Exp Med (1974) 2.01
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media. J Immunol Methods (1973) 1.97
Lymphocyte reactivity in vitro. I. Cellular reconstitution of purified lymphocyte response. Cell Immunol (1970) 1.97
The herpes simplex virus vhs protein induces endoribonucleolytic cleavage of target RNAs in cell extracts. J Virol (1999) 1.96
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes. Science (1975) 1.91
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med (1995) 1.90
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants. Nature (1985) 1.82
Antigenic requirements for triggering of cytotoxic T lymphocytes. Immunol Rev (1977) 1.82
An alpha-D-galactosyl-binding lectin from Bandeiraea simplicifolia seeds. Isolation by affinity chromatography and characterization. J Biol Chem (1974) 1.82
Lymphocyte reactivity in vitro. II. Soluble reconstituting factor permitting response of purified lymphocyte. Cell Immunol (1970) 1.74
Antigen-driven helper cell-independent cloned cytolytic T lymphocytes. Nature (1981) 1.72
Allogeneic and xenogeneic response in mixed leukocyte cultures. J Exp Med (1972) 1.70
Five HLA-D clusters associated with HLA-DR4. Hum Immunol (1982) 1.70
In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol (1994) 1.67
Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells. Nature (1976) 1.64
Monoclonal antibodies to the porcine intestinal receptor for 1,25-dihydroxyvitamin D3: interaction with distinct receptor domains. Biochemistry (1986) 1.64
Specificity of allogeneic cell recognition by human lymphocytes in vitro. Science (1971) 1.62
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
Cell kinetic studies in mixed leukocyte cultures: an in vitro model of homograft reactivity. Proc Natl Acad Sci U S A (1969) 1.61
Lymphocyte studies in congenital thymic dysplasia: The one-way stimulation test. J Pediatr (1968) 1.59
Impaired immunity in vitamin A-deficient mice. J Nutr (1987) 1.56
The molecular basis of alloreactivity. Immunol Today (1990) 1.56
Use of HLA loss mutants to analyse the structure of the human major histocompatibility complex. Nature (1982) 1.56
Mouse cell-mediated lympholysis assay in serum-free and mouse serum-supplemented media: culture conditions and genetic factors. Scand J Immunol (1975) 1.55
Genetic control of cell-mediated lympholysis in mouse. J Exp Med (1974) 1.51
TCGF production for cloning and growth of functional human T lymphocytes. Scand J Immunol (1980) 1.50
Alternative pathways of T lymphocyte activation. J Exp Med (1978) 1.49
Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr Biol (2001) 1.49
Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med (1996) 1.49
Call for moratorium on xenotransplants. Nature (1998) 1.48
Specificity of antigen recognition by human lymphocytes in vitro. Science (1970) 1.48
Continuous culture of T cells cytotoxic for autologous human leukaemia cells. Nature (1979) 1.46
Lymphocyte reactivity to serologically undetected components of the major histocompatibility complex. Nat New Biol (1973) 1.44
Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes (2001) 1.43
Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42
The fornix in patients with seizures caused by unilateral hippocampal sclerosis: detection of unilateral volume loss on MR images. AJR Am J Roentgenol (1994) 1.42
Dw/LD-related molecular polymorphism of DR4 beta-chains. J Exp Med (1983) 1.42
Human mixed lymphocyte cultures. Evaluation of a microculture technique utilizing the Multiple Automated Sample Harvester (MASH). Clin Exp Immunol (1973) 1.41
Evidence for differential induction of helper T cell subsets during Trichinella spiralis infection. J Immunol (1989) 1.41
1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol (1998) 1.41
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells. Nature (1978) 1.41
Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J Immunol (1996) 1.40
SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines. Nature (1981) 1.40
Human lymphocytes recognise mouse alloantigens. Nature (1975) 1.31
Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis. J Biol Chem (1996) 1.30
Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J Immunol (1998) 1.29
Transplantation: pairing of donor and recipient. Science (1970) 1.28
The major histocompatibility complex - genetics and biology (third of three parts). N Engl J Med (1976) 1.28
A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood (1998) 1.27
Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta. J Immunol (1987) 1.26
Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet (1971) 1.26
Regulation of the tissue factor promoter in endothelial cells. Binding of NF kappa B-, AP-1-, and Sp1-like transcription factors. J Biol Chem (1995) 1.26
Cytotoxicity: specificity after in vitro sensitization. Science (1970) 1.26
Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation (1991) 1.24
NK-kappa B subunit-specific regulation of the I kappa B alpha promoter. J Biol Chem (1994) 1.24
Specificity of cell-mediated lympholysis for public and private H-2 determinants. Scand J Immunol (1975) 1.24
Release of heparan sulfate from endothelial cells. Implications for pathogenesis of hyperacute rejection. J Exp Med (1990) 1.23
Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts. J Exp Med (1990) 1.23
Magnetic resonance neurography. Lancet (1993) 1.23
A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J Exp Med (1999) 1.22
Abrogation of cytotoxicity of mixed leukocyte cultures. Transplant Proc (1972) 1.21
Genetic control of mixed leukocyte culture reactivity. Transplant Rev (1972) 1.21
Lysis of leukemia cells by spleen cells of normal mice. Proc Natl Acad Sci U S A (1975) 1.20
Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur J Immunol (1991) 1.20
Intensity correction of phased-array surface coil images. Magn Reson Med (1996) 1.20
Abnormal regulation of IFN-gamma secretion in vitamin A deficiency. J Immunol (1991) 1.19
OKT4+ cytotoxic T cells can lyse targets via class I molecules and can be blocked by monoclonal antibody against T4 molecules. J Immunol (1984) 1.18
Genetic and cellular aspects of xenogeneic mixed leukocyte culture reaction. J Exp Med (1976) 1.16
Helper cell-independent cytolytic T lymphocytes specific for a minor histocompatibility antigen. J Immunol (1983) 1.15
Isolation and characterization of NK cell or NK/T cell-specific cDNA clones. J Mol Cell Immunol (1990) 1.14